E 路抗糖 | 降糖又安 「 心 」！二甲双胍的心血管获益，证据看过来！

参考文献

1. IDF Diabetes Atlas, 10th edition. 2021.

2. 中华医学会糖尿病学分会. 中华糖尿病杂志. 2021; 13(4): 315-409.

3. Hong J, et al. Diabetes Care. 2013; 36(5): 1304-1311.

4. Kooy A, et al. Arch Intern Med. 2009; 169(6): 616-625.

5. Holman RR, et al. N Engl J Med. 2008; 359(15): 1577-1589.

6. UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998(9131); 352: 854-865.

7. Goldberg RB, et al. Circulation. 2017; 136(1): 52-64.

8. Roussel R, et al. Arch Intern Med. 2010; 170(21): 1892-1899.

9. Aguilar D, et al. Circ Heart Fail. 2011; 4(1): 53-58.

10. Mellbin LG, et al. Diabetologia. 2011; 54(6): 1308-1317.

11. Lu DY, et al. BMC Cardiovasc Disord. 2014; 14: 187.

12. Paul SK, et al. J Diabetes. 2016; 8(3): 354-362.

13. Kao J, et al. Am J Cardiol. 2004; 93(11): 1347-1350.

14. Johnson JA, et al. Diabet Med. 2005; 22(4): 497-502.

15. Eurich DT, et al. Diabetes Care. 2005; 28(10): 2345-2351.

16. Andersson C, et al. Diabetologia. 2010; 53(12): 2546-2553.

17. Fácila L, et al. J Cardiovasc Med (Hagerstown). 2017; 18(2): 69-73.

18. Pantalone KM, et al. Acta Diabetol. 2009; 46(2): 145-154.

19. Chang CH, et al. J Clin Endocrinol Metab. 2015; 100(3): 1121-1129.

20. Fung CS, et al. Cardiovasc Diabetol. 2015; 14: 137.

21. Roumie CL, et al. Ann Intern Med. 2012; 157(9): 601-610.

22. Morgan CL, et al. Diabetes Obes Metab. 2014; 16(10): 957-962.

23. Evans JM, et al. Diabetologia. 2006; 49(5): 930-936.

24. Eurich DT, et al. Circ Heart Fail. 2013; 6(3): 395-402.

25. Crowley MJ, et al. Diabetes Care. 2017; 40(12): 1787-1789.

26. Saenz A, et al. Cochrane Database Syst Rev. 2005 Jul 20; (3): CD002966.

27. Pladevall M, et al. BMC Cardiovasc Disord. 2016; 16: 14.

28. Lamanna C, et al. Diabetes Obes Metab. 2011; 13(3): 221-228.

29. Rao AD, et al. Diabetes Care. 2008; 31(8): 1672-1678.

30. Ritsinger V, et al. Diab Vasc Dis Res. 2020; 17(6): 1479164120973676.

31. He S, et al. J Diabetes Res. 2021; 2021: 5534387.

32. Lin CS, et al. BMJ Open Diabetes Res Care. 2020; 8(2): e001351. 

33. Aimin Yang, et al. Long-Term Metformin Use and Risk of Death and CV-Renal Outcomes in Type 2 Diabetes with Chronic Kidney Disease (Stage 1-4). ADA2021-1013-P.

34. Shin H, et al. Ann Intern Med. 2022; 175(7): 927-937.

35. Romero R, et al. Am J Obstet Gynecol. 2017; 217(3): 282-302.

36. Trends of First-Line Antidiabetic Treatment among 2007-2017 Medicare Beneficiaries Newly Diagnosed with Type 2 Diabetes (T2D) and Their Determinants . ADA2021- 1107-P. 

37. Analysis of Medication Use in Type 2 Diabetes Mellitus in Korea Using a Common Data Model Based on the Claim Data of the Health Insurance Review and Assessment Service. ADA2021- 1096-P. 

38. American Diabetes Association. Diabetes Care. 2022; 45(Suppl 1): S125-S143.

39. Garber AJ, et al. Endocr Pract. 2020; 26(1):107-139.

40. Buse JB, et al. Diabetes Care. 2020; 43(2): 487-493.

41. Arnett DK, et al. J Am Coll Cardiol. 2019; 74(10): 1376-1414.

（来源：《国际糖尿病》编辑部）